Dr. Kristi Anseth, Howard Hughes Medical Investigator at the University of Colorado in Boulder
Kristi Anseth is a Tisone Distinguished Professor of Chemical and Biological Engineering and a Howard Hughes Medical Investigator at the University of Colorado in Boulder. She designs synthetic hydrogel biomaterials to imitate the extracellular matrix surrounding cells. Her pioneering approach is to apply photopolymerization and photodegradation to enable precise control in space and time over hydrogels' structure and composition, enabling fundamental investigations into the molecular dynamics of processes at the cell-biomaterial interface.
Dr. Cornelia Dekker, Medical Director of Stanford-LPCH Vaccine Program, Stanford's School of Medicine
Dr. Dekker specializes in immunology and has had 12 years of clinical vaccine industry experience before coming to Stanford. She currently serves as the IRB Reviewer for Stanford Administrative Panel on Human Subjects in Medical Research. A recipient of the 2008 Excellence in Teaching at Stanford's School of Medicine, Dr. Cornelia completed her internship, residency and fellowship at Duke University Medical School.
Dr. Jennifer Walske, Director of Social Entrepreneurship, University of California, Berkeley
Dr. Walske co-founded Myriad Investments, LLC in 2000 and currently serves as a Managing Director. She is a member of the Academy of Management and a member of the National Venture Capital Association. A recipient of the Earl F. Cheit Outstanding Teaching Award at the Haas School of Business, Dr. Walske was also ranked second in research excellence worldwide by the Institutional All American in Technical Software in 1999.